Specifically, by increasing extracellular Pi, at concentrations observed in CKD, we demonstrate that hyperphosphatemia inhibits the CaSR in a noncompetitive manner and thus increases PTH secretion. This evidence concerns the gene CASR and chronic kidney disease.